Skip to main content
. 2018 May 8;8:7294. doi: 10.1038/s41598-018-25439-z

Table 4.

Clinical outcomes according to baseline FGF23 quartile.

All Patients without baseline anemia (n = 1,164)
Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-for trend
N (%) N (%) N (%) N (%)
Newly developed anemia during follow-up 295 (25.3%) 48 (16.5%) 63 (21.6%) 91 (31.3%) 93 (32.0%) <0.001

Abbreviations: FGF23, fibroblast growth factor 23.